262 related articles for article (PubMed ID: 19837294)
1. Vaccines for Venezuelan equine encephalitis.
Paessler S; Weaver SC
Vaccine; 2009 Nov; 27 Suppl 4():D80-5. PubMed ID: 19837294
[TBL] [Abstract][Full Text] [Related]
2. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P
Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629
[TBL] [Abstract][Full Text] [Related]
3. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
[TBL] [Abstract][Full Text] [Related]
4. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.
Jahrling PB; Stephenson EH
J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512
[TBL] [Abstract][Full Text] [Related]
6. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
Atasheva S; Kim DY; Frolova EI; Frolov I
J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
[TBL] [Abstract][Full Text] [Related]
7. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
[TBL] [Abstract][Full Text] [Related]
8. Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection.
Paessler S; Yun NE; Judy BM; Dziuba N; Zacks MA; Grund AH; Frolov I; Campbell GA; Weaver SC; Estes DM
Virology; 2007 Oct; 367(2):307-23. PubMed ID: 17610927
[TBL] [Abstract][Full Text] [Related]
9. IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
Rossi SL; Guerbois M; Gorchakov R; Plante KS; Forrester NL; Weaver SC
Virology; 2013 Mar; 437(2):81-8. PubMed ID: 23351391
[TBL] [Abstract][Full Text] [Related]
10. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
[TBL] [Abstract][Full Text] [Related]
11. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
[TBL] [Abstract][Full Text] [Related]
13. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
[TBL] [Abstract][Full Text] [Related]
14. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.
Dupuy LC; Richards MJ; Ellefsen B; Chau L; Luxembourg A; Hannaman D; Livingston BD; Schmaljohn CS
Clin Vaccine Immunol; 2011 May; 18(5):707-16. PubMed ID: 21450977
[TBL] [Abstract][Full Text] [Related]
15. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
Braid LR; Hu WG; Davies JE; Nagata LP
Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.
Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL
Vaccine; 2010 Apr; 28(18):3143-51. PubMed ID: 20193792
[TBL] [Abstract][Full Text] [Related]
17. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).
Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B
J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494
[TBL] [Abstract][Full Text] [Related]
18. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
Front Immunol; 2020; 11():598847. PubMed ID: 33542715
[TBL] [Abstract][Full Text] [Related]
19. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates.
Dupuy LC; Richards MJ; Reed DS; Schmaljohn CS
Vaccine; 2010 Oct; 28(46):7345-50. PubMed ID: 20851089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
